ReVision CEO John Kilcoyne Says the Company is Ready to Build a New Medtech Market in Ophthalmology
Aug 11, 2016
27:34
Episode Description
ReVision Optics built it – a corneal inlay capable of correcting presbyopia. The FDA approved it sooner than expected. Now the company needs to build it into a successful private-pay business.
Proudly Supported by
Patrons of Health Podcast Library
Supporting Shows
